Comparison of four methods to assess high-on platelet reactivity under P2Y12 receptor inhibitor

P2Y12 receptor inhibitors are antiplatelet agents commonly prescribed in the treatment of coronary artery disease. Their efficacy can be limited by high on-treatment platelet reactivity (HPR), which can be evaluated by different biological assays. Most commonly, HPR is evaluated by flow cytometric v...

Description complète

Détails bibliographiques

Auteurs principaux:	Fanny Mingant, Romain Didier, Martine Gilard, Françoise Martin, Pierre-Philippe Nicol, Valérie Ugo, Eric Lippert, Hubert Galinat
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2018-04-01
Collection:	Platelets
Sujets:	high on-treatment platelet reactivity (hpr) light transmittance aggregometry (lta) multiple electrode aggregometry (mea) p2y12 receptor inhibitors platelet function analyzer (pfa) vasodilator-stimulated phosphoprotein (vasp)
Accès en ligne:	http://dx.doi.org/10.1080/09537104.2018.1453058
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!